Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|November 27, 2015
Application of RNA-Seq Technology in Cancer ChemopreventionFrauke Goeman, Maurizio FanciulliInternational Review of Cell and Molecular Biology|July 22, 2017
MicroRNAs as Key Effectors in the p53 NetworkFrauke Goeman, Sabrina Strano, Giovanni BlandinoMethods in Molecular Biology (Clifton, N.J.)|November 15, 2012
ChIP-on-chip to identify mutant p53 targetsFrauke Goeman, Giulia Fontemaggi, Giovanni BlandinoMethods in Molecular Biology (Clifton, N.J.)|July 22, 2022
Dissecting the Epigenome Driving Drug Resistance by ATAC-SeqFrancesca de Nicola, Giacomo Corleone, Frauke GoemanBiochimica Et Biophysica Acta|June 3, 2008
ING2 recruits histone methyltransferase activity with methylation site specificity distinct from histone H3 lysines 4 and 9Frauke Goeman, Katja Otto, Sergiy Kyrylenko, et al.Molecular and Cellular Biology|December 17, 2004
Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of RasFrauke Goeman, Dorit Thormeyer, Maria Abad, et al.Omics : a Journal of Integrative Biology|February 22, 2011
ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promotersStefania Dell'Orso, Giulia Fontemaggi, Perry Stambolsky, et al.Cell Death & Disease|August 20, 2024
Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancerValeria Canu, Sebastiano Vaccarella, Andrea Sacconi, et al.Biochimica Et Biophysica Acta|June 16, 2007
Alien inhibits E2F1 gene expression and cell proliferationStephan P Tenbaum, Maria Papaioannou, Christina A Reeb, et al.Journal of Proteome Research|October 13, 2007
The tumor suppressors p33ING1 and p33ING2 interact with alien in vivo and enhance alien-mediated gene silencingInga Fegers, Robert Kob, Maren Eckey, et al.Pageof 6